1
HIV/STI Counseling and Care Center, Kermanshah University of Medical Sciences,
2
Department of Infectious Diseases, NRITLD, Shaheed Beheshti University of Medical Sciences, TEHRAN-IRAN
Abstract
Background: Due to increased prevalence of tuberculosis among HIV-infected patients, INH (Isoniazid) chemoprophylaxis has a major impact on the development of clinical tuberculosis. Materials and Methods: For the evaluation of INH effect on prevention, we used INH, 300 mg daily for 115 available TST (tuberculin skin test) positive HIV-infected patients for twelve months. Results: During three-year follow up, only twelve patients developed tuberculosis which was significantly lower than minimum estimated rate among these patients (>10% per year). Conclusion: We conclude that INH prophylaxis was effective method to prevent clinical tuberculosis among TST positive HIV-infected patients. (Tanaffos 2003; 2(5): 57-61)
Alaei,K , Mansoori,D and Alaei,A . (2003). The Effect of One Year INH Prophylaxis in Reduction of Clinical TB in HIV-Infected Injecting Drug User Males. TANAFFOS (Respiration), 2(1(winter)), 57-61.
MLA
Alaei,K , , Mansoori,D , and Alaei,A . "The Effect of One Year INH Prophylaxis in Reduction of Clinical TB in HIV-Infected Injecting Drug User Males", TANAFFOS (Respiration), 2, 1(winter), 2003, 57-61.
HARVARD
Alaei K, Mansoori D, Alaei A. (2003). 'The Effect of One Year INH Prophylaxis in Reduction of Clinical TB in HIV-Infected Injecting Drug User Males', TANAFFOS (Respiration), 2(1(winter)), pp. 57-61.
CHICAGO
K Alaei, D Mansoori and A Alaei, "The Effect of One Year INH Prophylaxis in Reduction of Clinical TB in HIV-Infected Injecting Drug User Males," TANAFFOS (Respiration), 2 1(winter) (2003): 57-61,
VANCOUVER
Alaei K, Mansoori D, Alaei A. The Effect of One Year INH Prophylaxis in Reduction of Clinical TB in HIV-Infected Injecting Drug User Males. TANAFFOS (Respiration). 2003;2(1(winter)):57-61.
